Healthcare -
Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
RARE - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities RARE - Ultragenyx Pharmaceutical Inc.
168 M
LAST VALUE
69.11%
2 YEAR CAGR
47.75%
5 YEAR CAGR
18.63%
10 YEAR CAGR